Cherry Tree Wealth Management’s Boston Scientific BSX Stock Holding History

Cherry Tree Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69K	Hold	63	–	–	﹤0.01%	523
2026 Q1	$3.95K	Hold	63	–	–	﹤0.01%	500
2025 Q4	$6.01K	Hold	63	–	–	﹤0.01%	474
2025 Q3	$6.15K	Sell	63 -150	-70%	-$15.5K	﹤0.01%	456
2025 Q2	$22.9K	Sell	213 -41	-16%	-$4.15K	0.01%	328
2025 Q1	$25.6K	Hold	254	–	–	0.01%	315
2024 Q4	$22.7K	Sell	254 -118	-32%	-$10.4K	0.01%	321
2024 Q3	$31.2K	Sell	372 -199	-35%	-$15.7K	0.01%	298
2024 Q2	$44K	Hold	571	–	–	0.01%	257
2024 Q1	$39.1K	Hold	571	–	–	0.01%	271
2023 Q4	$33K	Hold	571	–	–	0.01%	269
2023 Q3	$30.1K	Buy	571 +63	+12%	+$3.3K	0.01%	262
2023 Q2	$27.5K	Buy	+508	New	+$26.5K	0.01%	268

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cherry Tree Wealth Management's BSX Position: Q2 2026 in Review

Cherry Tree Wealth Management held its Boston Scientific (BSX) position steady in Q2 2026 at 63 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Cherry Tree Wealth Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $44K in Q2 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cherry Tree Wealth Management held 63 shares of Boston Scientific worth $2.69K as of Q2 2026.
Cherry Tree Wealth Management left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q2 2026, its #523 holding.
Cherry Tree Wealth Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
Cherry Tree Wealth Management's Boston Scientific position peaked at $44K in Q2 2024.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q2 2026, filed 15 Sep 2026.